This article comes from “infowars.com”
Texas Attorney General Ken Paxton is suing Pfizer for misrepresenting the effectiveness of the pharmaceutical giant’s COVID-19 vaccine and attempting to censor public discussion of the product.
“Pfizer engaged in false, deceptive, and misleading acts and practices by making unsupported claims regarding the company’s COVID-19 vaccine in violation of the Texas Deceptive Trade Practices Act,” reads a Thursday press release from Paxton.
BREAKING:🚨 I am suing Pfizer for misrepresenting Covid-19 vaccine efficacy and conspiring to censor public discourse. pic.twitter.com/63mZ1y6FNC
— Attorney General Ken Paxton (@KenPaxtonTX) November 30, 2023
The statement slams Pfizer for its “campaign to intimidate” the public into getting jabbed over a “highly misleading” claim that the vaccine had 95% efficacy against infection.
“…Pfizer fostered a misleading impression that vaccine protection was durable and withheld from the public information that undermined its claims about the duration of protection. And, despite the fact that its clinical trial failed to measure whether the vaccine protects against transmission, Pfizer embarked on a campaign to intimate the public into getting the vaccine as a necessary measure to protect their loved ones.”
According to the lawsuit, Pfizer silenced critics when the vaccine’s failure “became apparent.”
“How did Pfizer respond when it became apparent that its vaccine was failing and the viability of its cash cow under threat? By intimidating those spreading the truth, and by conspiring to censor the vaccine’s critics. Pfizer labeled as “criminals” those who spread facts about the vaccine. It accused them of spreading “misinformation.” And it coerced social media platforms to silence prominent truth-tellers.”
Read & share Paxton’s lawsuit below:
TX Pfizer Petition by The Federalist
This should be interesting to watch. Hope Paxton is ready to weather the storm, and that he has good security. https://t.co/tz0s0rc7q6
— Robert W Malone, MD (@RWMaloneMD) November 30, 2023